Article Details

Lilly signs deal with California biotech to develop treatments for Lou Gehrig's disease

Retrieved on: 2021-07-08 16:41:15

Tags for this article:

Click the tags to see associated articles and topics

Lilly signs deal with California biotech to develop treatments for Lou Gehrig's disease. View article details on hiswai:

Excerpt

Lilly has its own neuroscience portfolio, which include medicines for schizophrenia, depression and pain. It also has a pipeline of experimental ...

Article found on: www.ibj.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up